First-in-Class Dual EZH2-HSP90 Inhibitor Eliciting Striking Antiglioblastoma Activity In Vitro and In Vivo

Author:

Sharma Sachin1,Wang Shao-An2ORCID,Yang Wen-Bin3,Lin Hong-Yi4,Lai Mei-Jung5,Chen Hsien-Chung367,Kao Tzu-Yuan17,Hsu Feng-Lin2,Nepali Kunal158ORCID,Hsu Tsung-I357910ORCID,Liou Jing-Ping15108ORCID

Affiliation:

1. School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan

2. School of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei 110, Taiwan

3. TMU Research Center of Neuroscience, Taipei Medical University, Taipei 110, Taiwan

4. Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan

5. TMU Research Center for Drug Discovery, Taipei Medical University, Taipei 110, Taiwan

6. Department of Neurosurgery, Shuang Ho Hospital, Taipei Medical University, Taipei 110, Taiwan

7. Ph.D. Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei 110, Taiwan

8. Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan

9. International Master Program in Medical Neuroscience, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan

10. TMU Research Center of Cancer Translational Medicine, Taipei 110 Taiwan

Funder

National Science and Technology Council

Ministry of Education, Taiwan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3